Block COVID-19, Colds, And Flu – With A BioSURE Nasal Spray.
BioSure Global (the team behind the world’s first ever CE-marked HIV self-test) has launched another innovative product: the BioSURE PRO Protective Nasal Spray.
BioSure Global was launched in 2011 by Brigette Bard.
The new BioSURE spray creates a physical barrier that helps to prevent infections caused by rotavirus A (sickness and diarrhoea), RSV (common colds), influenzas (flu), and coronaviruses, including COVID-19, before they even start.
The spray coats the nasal membranes, and forms a film – to create an invisible, physical barrier that stops colds, flus, and coronaviruses from attaching to the cells in your nose. If the viruses can’t connect, they can’t infect.
“The last few years of COVID-19 have been tough enough, and now there is talk of a ‘tripledemic.’ We need as many tools as possible to keep us all functioning physically and mentally! BioSURE PRO is effective at blocking the 3 ‘tripledemic’ viruses, RSV, flu, and COVID-19. Take action before you catch an infection, instead of reacting when you have symptoms,” said BioSURE’s Brigette Bard.
The BioSURE PRO Protective Nasal Spray is UKCA-marked, and it’s MHRA registered. It’s also undergoing Notified Body CE marking for sales into Europe, with certification anticipated by Q1 2023. The award-winning formula is already proving to be successful in the USA under the Covixyl brand name.
Under Brigette Bard’s leadership, BioSure launched the world’s first ever approved HIV blood-testing kit in 2015, which is over 99.7 percent accurate. Brigette is actively involved in normalising the conversation around HIV as a disease, as well as encouraging people to test for it.
Find out more here: https://bebiosure.com